Biogenic Stimulant market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Biogenic Stimulant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Humic Substances Seaweed Extracts Microbial Amendments Trace Minerals Vitamins & Amino Acids Others Segment by Application Foilar Soil Seed By Company BASF SE Dow AgroSciences Dupont Novozymes A/S Isagro SAP Sapec Group Platform Specialty Products Corporation Biolchim S.P.A Valagro SAP Koppert B.V Biostadt India Limited Italpollina SAP Huma Gro Production by Region North America Europe China Japan Consumption by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
1 Study Coverage 1.1 Biogenic Stimulant Product Introduction 1.2 Market by Type 1.2.1 Global Biogenic Stimulant Market Size by Type, 2017 VS 2021 VS 2028 1.2.2 Humic Substances 1.2.3 Seaweed Extracts 1.2.4 Microbial Amendments 1.2.5 Trace Minerals 1.2.6 Vitamins & Amino Acids 1.2.7 Others 1.3 Market by Application 1.3.1 Global Biogenic Stimulant Market Size by Application, 2017 VS 2021 VS 2028 1.3.2 Foilar 1.3.3 Soil 1.3.4 Seed 1.4 Study Objectives 1.5 Years Considered 2 Global Biogenic Stimulant Production 2.1 Global Biogenic Stimulant Production Capacity (2017-2028) 2.2 Global Biogenic Stimulant Production by Region: 2017 VS 2021 VS 2028 2.3 Global Biogenic Stimulant Production by Region 2.3.1 Global Biogenic Stimulant Historic Production by Region (2017-2022) 2.3.2 Global Biogenic Stimulant Forecasted Production by Region (2023-2028) 2.4 North America 2.5 Europe 2.6 China 2.7 Japan 3 Global Biogenic Stimulant Sales in Volume & Value Estimates and Forecasts 3.1 Global Biogenic Stimulant Sales Estimates and Forecasts 2017-2028 3.2 Global Biogenic Stimulant Revenue Estimates and Forecasts 2017-2028 3.3 Global Biogenic Stimulant Revenue by Region: 2017 VS 2021 VS 2028 3.4 Global Biogenic Stimulant Sales by Region 3.4.1 Global Biogenic Stimulant Sales by Region (2017-2022) 3.4.2 Global Sales Biogenic Stimulant by Region (2023-2028) 3.5 Global Biogenic Stimulant Revenue by Region 3.5.1 Global Biogenic Stimulant Revenue by Region (2017-2022) 3.5.2 Global Biogenic Stimulant Revenue by Region (2023-2028) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Biogenic Stimulant Production Capacity by Manufacturers 4.2 Global Biogenic Stimulant Sales by Manufacturers 4.2.1 Global Biogenic Stimulant Sales by Manufacturers (2017-2022) 4.2.2 Global Biogenic Stimulant Sales Market Share by Manufacturers (2017-2022) 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Biogenic Stimulant in 2021 4.3 Global Biogenic Stimulant Revenue by Manufacturers 4.3.1 Global Biogenic Stimulant Revenue by Manufacturers (2017-2022) 4.3.2 Global Biogenic Stimulant Revenue Market Share by Manufacturers (2017-2022) 4.3.3 Global Top 10 and Top 5 Companies by Biogenic Stimulant Revenue in 2021 4.4 Global Biogenic Stimulant Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Biogenic Stimulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Biogenic Stimulant Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Biogenic Stimulant Sales by Type 5.1.1 Global Biogenic Stimulant Historical Sales by Type (2017-2022) 5.1.2 Global Biogenic Stimulant Forecasted Sales by Type (2023-2028) 5.1.3 Global Biogenic Stimulant Sales Market Share by Type (2017-2028) 5.2 Global Biogenic Stimulant Revenue by Type 5.2.1 Global Biogenic Stimulant Historical Revenue by Type (2017-2022) 5.2.2 Global Biogenic Stimulant Forecasted Revenue by Type (2023-2028) 5.2.3 Global Biogenic Stimulant Revenue Market Share by Type (2017-2028) 5.3 Global Biogenic Stimulant Price by Type 5.3.1 Global Biogenic Stimulant Price by Type (2017-2022) 5.3.2 Global Biogenic Stimulant Price Forecast by Type (2023-2028) 6 Market Size by Application 6.1 Global Biogenic Stimulant Sales by Application 6.1.1 Global Biogenic Stimulant Historical Sales by Application (2017-2022) 6.1.2 Global Biogenic Stimulant Forecasted Sales by Application (2023-2028) 6.1.3 Global Biogenic Stimulant Sales Market Share by Application (2017-2028) 6.2 Global Biogenic Stimulant Revenue by Application 6.2.1 Global Biogenic Stimulant Historical Revenue by Application (2017-2022) 6.2.2 Global Biogenic Stimulant Forecasted Revenue by Application (2023-2028) 6.2.3 Global Biogenic Stimulant Revenue Market Share by Application (2017-2028) 6.3 Global Biogenic Stimulant Price by Application 6.3.1 Global Biogenic Stimulant Price by Application (2017-2022) 6.3.2 Global Biogenic Stimulant Price Forecast by Application (2023-2028) 7 North America 7.1 North America Biogenic Stimulant Market Size by Type 7.1.1 North America Biogenic Stimulant Sales by Type (2017-2028) 7.1.2 North America Biogenic Stimulant Revenue by Type (2017-2028) 7.2 North America Biogenic Stimulant Market Size by Application 7.2.1 North America Biogenic Stimulant Sales by Application (2017-2028) 7.2.2 North America Biogenic Stimulant Revenue by Application (2017-2028) 7.3 North America Biogenic Stimulant Sales by Country 7.3.1 North America Biogenic Stimulant Sales by Country (2017-2028) 7.3.2 North America Biogenic Stimulant Revenue by Country (2017-2028) 7.3.3 U.S. 7.3.4 Canada 8 Europe 8.1 Europe Biogenic Stimulant Market Size by Type 8.1.1 Europe Biogenic Stimulant Sales by Type (2017-2028) 8.1.2 Europe Biogenic Stimulant Revenue by Type (2017-2028) 8.2 Europe Biogenic Stimulant Market Size by Application 8.2.1 Europe Biogenic Stimulant Sales by Application (2017-2028) 8.2.2 Europe Biogenic Stimulant Revenue by Application (2017-2028) 8.3 Europe Biogenic Stimulant Sales by Country 8.3.1 Europe Biogenic Stimulant Sales by Country (2017-2028) 8.3.2 Europe Biogenic Stimulant Revenue by Country (2017-2028) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Biogenic Stimulant Market Size by Type 9.1.1 Asia Pacific Biogenic Stimulant Sales by Type (2017-2028) 9.1.2 Asia Pacific Biogenic Stimulant Revenue by Type (2017-2028) 9.2 Asia Pacific Biogenic Stimulant Market Size by Application 9.2.1 Asia Pacific Biogenic Stimulant Sales by Application (2017-2028) 9.2.2 Asia Pacific Biogenic Stimulant Revenue by Application (2017-2028) 9.3 Asia Pacific Biogenic Stimulant Sales by Region 9.3.1 Asia Pacific Biogenic Stimulant Sales by Region (2017-2028) 9.3.2 Asia Pacific Biogenic Stimulant Revenue by Region (2017-2028) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 9.3.12 Philippines 10 Latin America 10.1 Latin America Biogenic Stimulant Market Size by Type 10.1.1 Latin America Biogenic Stimulant Sales by Type (2017-2028) 10.1.2 Latin America Biogenic Stimulant Revenue by Type (2017-2028) 10.2 Latin America Biogenic Stimulant Market Size by Application 10.2.1 Latin America Biogenic Stimulant Sales by Application (2017-2028) 10.2.2 Latin America Biogenic Stimulant Revenue by Application (2017-2028) 10.3 Latin America Biogenic Stimulant Sales by Country 10.3.1 Latin America Biogenic Stimulant Sales by Country (2017-2028) 10.3.2 Latin America Biogenic Stimulant Revenue by Country (2017-2028) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Biogenic Stimulant Market Size by Type 11.1.1 Middle East and Africa Biogenic Stimulant Sales by Type (2017-2028) 11.1.2 Middle East and Africa Biogenic Stimulant Revenue by Type (2017-2028) 11.2 Middle East and Africa Biogenic Stimulant Market Size by Application 11.2.1 Middle East and Africa Biogenic Stimulant Sales by Application (2017-2028) 11.2.2 Middle East and Africa Biogenic Stimulant Revenue by Application (2017-2028) 11.3 Middle East and Africa Biogenic Stimulant Sales by Country 11.3.1 Middle East and Africa Biogenic Stimulant Sales by Country (2017-2028) 11.3.2 Middle East and Africa Biogenic Stimulant Revenue by Country (2017-2028) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 BASF SE 12.1.1 BASF SE Corporation Information 12.1.2 BASF SE Overview 12.1.3 BASF SE Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.1.4 BASF SE Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.1.5 BASF SE Recent Developments 12.2 Dow AgroSciences 12.2.1 Dow AgroSciences Corporation Information 12.2.2 Dow AgroSciences Overview 12.2.3 Dow AgroSciences Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.2.4 Dow AgroSciences Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.2.5 Dow AgroSciences Recent Developments 12.3 Dupont 12.3.1 Dupont Corporation Information 12.3.2 Dupont Overview 12.3.3 Dupont Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.3.4 Dupont Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.3.5 Dupont Recent Developments 12.4 Novozymes A/S 12.4.1 Novozymes A/S Corporation Information 12.4.2 Novozymes A/S Overview 12.4.3 Novozymes A/S Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.4.4 Novozymes A/S Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.4.5 Novozymes A/S Recent Developments 12.5 Isagro SAP 12.5.1 Isagro SAP Corporation Information 12.5.2 Isagro SAP Overview 12.5.3 Isagro SAP Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.5.4 Isagro SAP Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.5.5 Isagro SAP Recent Developments 12.6 Sapec Group 12.6.1 Sapec Group Corporation Information 12.6.2 Sapec Group Overview 12.6.3 Sapec Group Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.6.4 Sapec Group Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.6.5 Sapec Group Recent Developments 12.7 Platform Specialty Products Corporation 12.7.1 Platform Specialty Products Corporation Corporation Information 12.7.2 Platform Specialty Products Corporation Overview 12.7.3 Platform Specialty Products Corporation Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.7.4 Platform Specialty Products Corporation Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.7.5 Platform Specialty Products Corporation Recent Developments 12.8 Biolchim S.P.A 12.8.1 Biolchim S.P.A Corporation Information 12.8.2 Biolchim S.P.A Overview 12.8.3 Biolchim S.P.A Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.8.4 Biolchim S.P.A Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.8.5 Biolchim S.P.A Recent Developments 12.9 Valagro SAP 12.9.1 Valagro SAP Corporation Information 12.9.2 Valagro SAP Overview 12.9.3 Valagro SAP Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.9.4 Valagro SAP Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.9.5 Valagro SAP Recent Developments 12.10 Koppert B.V 12.10.1 Koppert B.V Corporation Information 12.10.2 Koppert B.V Overview 12.10.3 Koppert B.V Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.10.4 Koppert B.V Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.10.5 Koppert B.V Recent Developments 12.11 Biostadt India Limited 12.11.1 Biostadt India Limited Corporation Information 12.11.2 Biostadt India Limited Overview 12.11.3 Biostadt India Limited Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.11.4 Biostadt India Limited Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.11.5 Biostadt India Limited Recent Developments 12.12 Italpollina SAP 12.12.1 Italpollina SAP Corporation Information 12.12.2 Italpollina SAP Overview 12.12.3 Italpollina SAP Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.12.4 Italpollina SAP Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.12.5 Italpollina SAP Recent Developments 12.13 Huma Gro 12.13.1 Huma Gro Corporation Information 12.13.2 Huma Gro Overview 12.13.3 Huma Gro Biogenic Stimulant Sales, Price, Revenue and Gross Margin (2017-2022) 12.13.4 Huma Gro Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications 12.13.5 Huma Gro Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Biogenic Stimulant Industry Chain Analysis 13.2 Biogenic Stimulant Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Biogenic Stimulant Production Mode & Process 13.4 Biogenic Stimulant Sales and Marketing 13.4.1 Biogenic Stimulant Sales Channels 13.4.2 Biogenic Stimulant Distributors 13.5 Biogenic Stimulant Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Biogenic Stimulant Industry Trends 14.2 Biogenic Stimulant Market Drivers 14.3 Biogenic Stimulant Market Challenges 14.4 Biogenic Stimulant Market Restraints 15 Key Finding in The Global Biogenic Stimulant Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
List of Tables Table 1. Global Biogenic Stimulant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Humic Substances Table 3. Major Manufacturers of Seaweed Extracts Table 4. Major Manufacturers of Microbial Amendments Table 5. Major Manufacturers of Trace Minerals Table 6. Major Manufacturers of Vitamins & Amino Acids Table 7. Major Manufacturers of Others Table 8. Global Biogenic Stimulant Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million) Table 9. Global Biogenic Stimulant Production by Region: 2017 VS 2021 VS 2028 (K MT) Table 10. Global Biogenic Stimulant Production by Region (2017-2022) & (K MT) Table 11. Global Biogenic Stimulant Production Market Share by Region (2017-2022) Table 12. Global Biogenic Stimulant Production by Region (2023-2028) & (K MT) Table 13. Global Biogenic Stimulant Production Market Share by Region (2023-2028) Table 14. Global Biogenic Stimulant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 15. Global Biogenic Stimulant Sales by Region (2017-2022) & (K MT) Table 16. Global Biogenic Stimulant Sales Market Share by Region (2017-2022) Table 17. Global Biogenic Stimulant Sales by Region (2023-2028) & (K MT) Table 18. Global Biogenic Stimulant Sales Market Share by Region (2023-2028) Table 19. Global Biogenic Stimulant Revenue by Region (2017-2022) & (US$ Million) Table 20. Global Biogenic Stimulant Revenue Market Share by Region (2017-2022) Table 21. Global Biogenic Stimulant Revenue by Region (2023-2028) & (US$ Million) Table 22. Global Biogenic Stimulant Revenue Market Share by Region (2023-2028) Table 23. Global Biogenic Stimulant Production Capacity by Manufacturers (2017-2022) & (K MT) Table 24. Global Biogenic Stimulant Capacity Market Share by Manufacturers (2017-2022) Table 25. Global Biogenic Stimulant Sales by Manufacturers (2017-2022) & (K MT) Table 26. Global Biogenic Stimulant Sales Market Share by Manufacturers (2017-2022) Table 27. Global Biogenic Stimulant Revenue by Manufacturers (2017-2022) & (US$ Million) Table 28. Global Biogenic Stimulant Revenue Share by Manufacturers (2017-2022) Table 29. Biogenic Stimulant Price by Manufacturers 2017-2022 (USD/MT) Table 30. Global Biogenic Stimulant Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Biogenic Stimulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biogenic Stimulant as of 2021) Table 32. Biogenic Stimulant Manufacturing Base Distribution and Headquarters Table 33. Manufacturers Biogenic Stimulant Product Offered Table 34. Date of Manufacturers Enter into Biogenic Stimulant Market Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Biogenic Stimulant Sales by Type (2017-2022) & (K MT) Table 37. Global Biogenic Stimulant Sales by Type (2023-2028) & (K MT) Table 38. Global Biogenic Stimulant Sales Share by Type (2017-2022) Table 39. Global Biogenic Stimulant Sales Share by Type (2023-2028) Table 40. Global Biogenic Stimulant Revenue by Type (2017-2022) & (US$ Million) Table 41. Global Biogenic Stimulant Revenue by Type (2023-2028) & (US$ Million) Table 42. Global Biogenic Stimulant Revenue Share by Type (2017-2022) Table 43. Global Biogenic Stimulant Revenue Share by Type (2023-2028) Table 44. Biogenic Stimulant Price by Type (2017-2022) & (USD/MT) Table 45. Global Biogenic Stimulant Price Forecast by Type (2023-2028) & (USD/MT) Table 46. Global Biogenic Stimulant Sales by Application (2017-2022) & (K MT) Table 47. Global Biogenic Stimulant Sales by Application (2023-2028) & (K MT) Table 48. Global Biogenic Stimulant Sales Share by Application (2017-2022) Table 49. Global Biogenic Stimulant Sales Share by Application (2023-2028) Table 50. Global Biogenic Stimulant Revenue by Application (2017-2022) & (US$ Million) Table 51. Global Biogenic Stimulant Revenue by Application (2023-2028) & (US$ Million) Table 52. Global Biogenic Stimulant Revenue Share by Application (2017-2022) Table 53. Global Biogenic Stimulant Revenue Share by Application (2023-2028) Table 54. Biogenic Stimulant Price by Application (2017-2022) & (USD/MT) Table 55. Global Biogenic Stimulant Price Forecast by Application (2023-2028) & (USD/MT) Table 56. North America Biogenic Stimulant Sales by Type (2017-2022) & (K MT) Table 57. North America Biogenic Stimulant Sales by Type (2023-2028) & (K MT) Table 58. North America Biogenic Stimulant Revenue by Type (2017-2022) & (US$ Million) Table 59. North America Biogenic Stimulant Revenue by Type (2023-2028) & (US$ Million) Table 60. North America Biogenic Stimulant Sales by Application (2017-2022) & (K MT) Table 61. North America Biogenic Stimulant Sales by Application (2023-2028) & (K MT) Table 62. North America Biogenic Stimulant Revenue by Application (2017-2022) & (US$ Million) Table 63. North America Biogenic Stimulant Revenue by Application (2023-2028) & (US$ Million) Table 64. North America Biogenic Stimulant Sales by Country (2017-2022) & (K MT) Table 65. North America Biogenic Stimulant Sales by Country (2023-2028) & (K MT) Table 66. North America Biogenic Stimulant Revenue by Country (2017-2022) & (US$ Million) Table 67. North America Biogenic Stimulant Revenue by Country (2023-2028) & (US$ Million) Table 68. Europe Biogenic Stimulant Sales by Type (2017-2022) & (K MT) Table 69. Europe Biogenic Stimulant Sales by Type (2023-2028) & (K MT) Table 70. Europe Biogenic Stimulant Revenue by Type (2017-2022) & (US$ Million) Table 71. Europe Biogenic Stimulant Revenue by Type (2023-2028) & (US$ Million) Table 72. Europe Biogenic Stimulant Sales by Application (2017-2022) & (K MT) Table 73. Europe Biogenic Stimulant Sales by Application (2023-2028) & (K MT) Table 74. Europe Biogenic Stimulant Revenue by Application (2017-2022) & (US$ Million) Table 75. Europe Biogenic Stimulant Revenue by Application (2023-2028) & (US$ Million) Table 76. Europe Biogenic Stimulant Sales by Country (2017-2022) & (K MT) Table 77. Europe Biogenic Stimulant Sales by Country (2023-2028) & (K MT) Table 78. Europe Biogenic Stimulant Revenue by Country (2017-2022) & (US$ Million) Table 79. Europe Biogenic Stimulant Revenue by Country (2023-2028) & (US$ Million) Table 80. Asia Pacific Biogenic Stimulant Sales by Type (2017-2022) & (K MT) Table 81. Asia Pacific Biogenic Stimulant Sales by Type (2023-2028) & (K MT) Table 82. Asia Pacific Biogenic Stimulant Revenue by Type (2017-2022) & (US$ Million) Table 83. Asia Pacific Biogenic Stimulant Revenue by Type (2023-2028) & (US$ Million) Table 84. Asia Pacific Biogenic Stimulant Sales by Application (2017-2022) & (K MT) Table 85. Asia Pacific Biogenic Stimulant Sales by Application (2023-2028) & (K MT) Table 86. Asia Pacific Biogenic Stimulant Revenue by Application (2017-2022) & (US$ Million) Table 87. Asia Pacific Biogenic Stimulant Revenue by Application (2023-2028) & (US$ Million) Table 88. Asia Pacific Biogenic Stimulant Sales by Region (2017-2022) & (K MT) Table 89. Asia Pacific Biogenic Stimulant Sales by Region (2023-2028) & (K MT) Table 90. Asia Pacific Biogenic Stimulant Revenue by Region (2017-2022) & (US$ Million) Table 91. Asia Pacific Biogenic Stimulant Revenue by Region (2023-2028) & (US$ Million) Table 92. Latin America Biogenic Stimulant Sales by Type (2017-2022) & (K MT) Table 93. Latin America Biogenic Stimulant Sales by Type (2023-2028) & (K MT) Table 94. Latin America Biogenic Stimulant Revenue by Type (2017-2022) & (US$ Million) Table 95. Latin America Biogenic Stimulant Revenue by Type (2023-2028) & (US$ Million) Table 96. Latin America Biogenic Stimulant Sales by Application (2017-2022) & (K MT) Table 97. Latin America Biogenic Stimulant Sales by Application (2023-2028) & (K MT) Table 98. Latin America Biogenic Stimulant Revenue by Application (2017-2022) & (US$ Million) Table 99. Latin America Biogenic Stimulant Revenue by Application (2023-2028) & (US$ Million) Table 100. Latin America Biogenic Stimulant Sales by Country (2017-2022) & (K MT) Table 101. Latin America Biogenic Stimulant Sales by Country (2023-2028) & (K MT) Table 102. Latin America Biogenic Stimulant Revenue by Country (2017-2022) & (US$ Million) Table 103. Latin America Biogenic Stimulant Revenue by Country (2023-2028) & (US$ Million) Table 104. Middle East and Africa Biogenic Stimulant Sales by Type (2017-2022) & (K MT) Table 105. Middle East and Africa Biogenic Stimulant Sales by Type (2023-2028) & (K MT) Table 106. Middle East and Africa Biogenic Stimulant Revenue by Type (2017-2022) & (US$ Million) Table 107. Middle East and Africa Biogenic Stimulant Revenue by Type (2023-2028) & (US$ Million) Table 108. Middle East and Africa Biogenic Stimulant Sales by Application (2017-2022) & (K MT) Table 109. Middle East and Africa Biogenic Stimulant Sales by Application (2023-2028) & (K MT) Table 110. Middle East and Africa Biogenic Stimulant Revenue by Application (2017-2022) & (US$ Million) Table 111. Middle East and Africa Biogenic Stimulant Revenue by Application (2023-2028) & (US$ Million) Table 112. Middle East and Africa Biogenic Stimulant Sales by Country (2017-2022) & (K MT) Table 113. Middle East and Africa Biogenic Stimulant Sales by Country (2023-2028) & (K MT) Table 114. Middle East and Africa Biogenic Stimulant Revenue by Country (2017-2022) & (US$ Million) Table 115. Middle East and Africa Biogenic Stimulant Revenue by Country (2023-2028) & (US$ Million) Table 116. BASF SE Corporation Information Table 117. BASF SE Description and Major Businesses Table 118. BASF SE Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 119. BASF SE Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 120. BASF SE Recent Development Table 121. Dow AgroSciences Corporation Information Table 122. Dow AgroSciences Description and Major Businesses Table 123. Dow AgroSciences Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 124. Dow AgroSciences Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Dow AgroSciences Recent Development Table 126. Dupont Corporation Information Table 127. Dupont Description and Major Businesses Table 128. Dupont Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 129. Dupont Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Dupont Recent Development Table 131. Novozymes A/S Corporation Information Table 132. Novozymes A/S Description and Major Businesses Table 133. Novozymes A/S Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 134. Novozymes A/S Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 135. Novozymes A/S Recent Development Table 136. Isagro SAP Corporation Information Table 137. Isagro SAP Description and Major Businesses Table 138. Isagro SAP Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 139. Isagro SAP Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Isagro SAP Recent Development Table 141. Sapec Group Corporation Information Table 142. Sapec Group Description and Major Businesses Table 143. Sapec Group Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 144. Sapec Group Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 145. Sapec Group Recent Development Table 146. Platform Specialty Products Corporation Corporation Information Table 147. Platform Specialty Products Corporation Description and Major Businesses Table 148. Platform Specialty Products Corporation Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 149. Platform Specialty Products Corporation Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 150. Platform Specialty Products Corporation Recent Development Table 151. Biolchim S.P.A Corporation Information Table 152. Biolchim S.P.A Description and Major Businesses Table 153. Biolchim S.P.A Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 154. Biolchim S.P.A Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 155. Biolchim S.P.A Recent Development Table 156. Valagro SAP Corporation Information Table 157. Valagro SAP Description and Major Businesses Table 158. Valagro SAP Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 159. Valagro SAP Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 160. Valagro SAP Recent Development Table 161. Koppert B.V Corporation Information Table 162. Koppert B.V Description and Major Businesses Table 163. Koppert B.V Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 164. Koppert B.V Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 165. Koppert B.V Recent Development Table 166. Biostadt India Limited Corporation Information Table 167. Biostadt India Limited Description and Major Businesses Table 168. Biostadt India Limited Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 169. Biostadt India Limited Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 170. Biostadt India Limited Recent Development Table 171. Italpollina SAP Corporation Information Table 172. Italpollina SAP Description and Major Businesses Table 173. Italpollina SAP Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 174. Italpollina SAP Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 175. Italpollina SAP Recent Development Table 176. Huma Gro Corporation Information Table 177. Huma Gro Description and Major Businesses Table 178. Huma Gro Biogenic Stimulant Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 179. Huma Gro Biogenic Stimulant Product Model Numbers, Pictures, Descriptions and Specifications Table 180. Huma Gro Recent Development Table 181. Key Raw Materials Lists Table 182. Raw Materials Key Suppliers Lists Table 183. Biogenic Stimulant Distributors List Table 184. Biogenic Stimulant Customers List Table 185. Biogenic Stimulant Market Trends Table 186. Biogenic Stimulant Market Drivers Table 187. Biogenic Stimulant Market Challenges Table 188. Biogenic Stimulant Market Restraints Table 189. Research Programs/Design for This Report Table 190. Key Data Information from Secondary Sources Table 191. Key Data Information from Primary Sources List of Figures Figure 1. Biogenic Stimulant Product Picture Figure 2. Global Biogenic Stimulant Market Share by Type in 2021 & 2028 Figure 3. Humic Substances Product Picture Figure 4. Seaweed Extracts Product Picture Figure 5. Microbial Amendments Product Picture Figure 6. Trace Minerals Product Picture Figure 7. Vitamins & Amino Acids Product Picture Figure 8. Others Product Picture Figure 9. Global Biogenic Stimulant Market Share by Application in 2021 & 2028 Figure 10. Foilar Figure 11. Soil Figure 12. Seed Figure 13. Biogenic Stimulant Report Years Considered Figure 14. Global Biogenic Stimulant Capacity, Production and Utilization (2017-2028) & (K MT) Figure 15. Global Biogenic Stimulant Production Market Share by Region in Percentage: 2021 Versus 2028 Figure 16. Global Biogenic Stimulant Production Market Share by Region (2017-2022) Figure 17. Global Biogenic Stimulant Production Market Share by Region (2023-2028) Figure 18. Biogenic Stimulant Production Growth Rate in North America (2017-2028) & (K MT) Figure 19. Biogenic Stimulant Production Growth Rate in Europe (2017-2028) & (K MT) Figure 20. Biogenic Stimulant Production Growth Rate in China (2017-2028) & (K MT) Figure 21. Biogenic Stimulant Production Growth Rate in Japan (2017-2028) & (K MT) Figure 22. Global Biogenic Stimulant Sales 2017-2028 (K MT) Figure 23. Global Biogenic Stimulant Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 24. Global Biogenic Stimulant Revenue 2017-2028 (US$ Million) Figure 25. Global Biogenic Stimulant Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 26. Global Biogenic Stimulant Sales Market Share by Region (2017-2022) Figure 27. Global Biogenic Stimulant Sales Market Share by Region (2023-2028) Figure 28. North America Biogenic Stimulant Sales YoY (2017-2028) & (K MT) Figure 29. North America Biogenic Stimulant Revenue YoY (2017-2028) & (US$ Million) Figure 30. Europe Biogenic Stimulant Sales YoY (2017-2028) & (K MT) Figure 31. Europe Biogenic Stimulant Revenue YoY (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Biogenic Stimulant Sales YoY (2017-2028) & (K MT) Figure 33. Asia-Pacific Biogenic Stimulant Revenue YoY (2017-2028) & (US$ Million) Figure 34. Latin America Biogenic Stimulant Sales YoY (2017-2028) & (K MT) Figure 35. Latin America Biogenic Stimulant Revenue YoY (2017-2028) & (US$ Million) Figure 36. Middle East & Africa Biogenic Stimulant Sales YoY (2017-2028) & (K MT) Figure 37. Middle East & Africa Biogenic Stimulant Revenue YoY (2017-2028) & (US$ Million) Figure 38. The Biogenic Stimulant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 39. The Top 5 and 10 Largest Manufacturers of Biogenic Stimulant in the World: Market Share by Biogenic Stimulant Revenue in 2021 Figure 40. Biogenic Stimulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 41. Global Biogenic Stimulant Sales Market Share by Type (2017-2028) Figure 42. Global Biogenic Stimulant Revenue Market Share by Type (2017-2028) Figure 43. Global Biogenic Stimulant Sales Market Share by Application (2017-2028) Figure 44. Global Biogenic Stimulant Revenue Market Share by Application (2017-2028) Figure 45. North America Biogenic Stimulant Sales Market Share by Type (2017-2028) Figure 46. North America Biogenic Stimulant Revenue Market Share by Type (2017-2028) Figure 47. North America Biogenic Stimulant Sales Market Share by Application (2017-2028) Figure 48. North America Biogenic Stimulant Revenue Market Share by Application (2017-2028) Figure 49. North America Biogenic Stimulant Sales Share by Country (2017-2028) Figure 50. North America Biogenic Stimulant Revenue Share by Country (2017-2028) Figure 51. U.S. Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 52. Canada Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 53. Europe Biogenic Stimulant Sales Market Share by Type (2017-2028) Figure 54. Europe Biogenic Stimulant Revenue Market Share by Type (2017-2028) Figure 55. Europe Biogenic Stimulant Sales Market Share by Application (2017-2028) Figure 56. Europe Biogenic Stimulant Revenue Market Share by Application (2017-2028) Figure 57. Europe Biogenic Stimulant Sales Share by Country (2017-2028) Figure 58. Europe Biogenic Stimulant Revenue Share by Country (2017-2028) Figure 59. Germany Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 60. France Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 61. U.K. Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 62. Italy Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 63. Russia Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 64. Asia Pacific Biogenic Stimulant Sales Market Share by Type (2017-2028) Figure 65. Asia Pacific Biogenic Stimulant Revenue Market Share by Type (2017-2028) Figure 66. Asia Pacific Biogenic Stimulant Sales Market Share by Application (2017-2028) Figure 67. Asia Pacific Biogenic Stimulant Revenue Market Share by Application (2017-2028) Figure 68. Asia Pacific Biogenic Stimulant Sales Share by Region (2017-2028) Figure 69. Asia Pacific Biogenic Stimulant Revenue Share by Region (2017-2028) Figure 70. China Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 71. Japan Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 72. South Korea Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 73. India Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 74. Australia Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 75. Taiwan Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 76. Indonesia Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 77. Thailand Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 78. Malaysia Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 79. Philippines Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 80. Latin America Biogenic Stimulant Sales Market Share by Type (2017-2028) Figure 81. Latin America Biogenic Stimulant Revenue Market Share by Type (2017-2028) Figure 82. Latin America Biogenic Stimulant Sales Market Share by Application (2017-2028) Figure 83. Latin America Biogenic Stimulant Revenue Market Share by Application (2017-2028) Figure 84. Latin America Biogenic Stimulant Sales Share by Country (2017-2028) Figure 85. Latin America Biogenic Stimulant Revenue Share by Country (2017-2028) Figure 86. Mexico Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 87. Brazil Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 88. Argentina Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 89. Middle East and Africa Biogenic Stimulant Sales Market Share by Type (2017-2028) Figure 90. Middle East and Africa Biogenic Stimulant Revenue Market Share by Type (2017-2028) Figure 91. Middle East and Africa Biogenic Stimulant Sales Market Share by Application (2017-2028) Figure 92. Middle East and Africa Biogenic Stimulant Revenue Market Share by Application (2017-2028) Figure 93. Middle East and Africa Biogenic Stimulant Sales Share by Country (2017-2028) Figure 94. Middle East and Africa Biogenic Stimulant Revenue Share by Country (2017-2028) Figure 95. Turkey Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 96. Saudi Arabia Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 97. UAE Biogenic Stimulant Revenue (2017-2028) & (US$ Million) Figure 98. Biogenic Stimulant Value Chain Figure 99. Biogenic Stimulant Production Process Figure 100. Channels of Distribution Figure 101. Distributors Profiles Figure 102. Bottom-up and Top-down Approaches for This Report Figure 103. Data Triangulation Figure 104. Key Executives Interviewed